The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
本发明提供了化合物、其组合物以及使用这些化合物来抑制TYK2并治疗TYK2介导的疾病的方法。
Hypoxia Activated Drugs Of Nitrogen Mustard Alkylators
申请人:Lewis Jason
公开号:US20110190310A1
公开(公告)日:2011-08-04
Hypoxia activated drug compounds having a structure of formula (I) are useful in the treatment of cancer and other hyperproliferative diseases.
具有公式(I)结构的缺氧激活药物化合物在癌症和其他过度增生性疾病的治疗中是有用的。
TYK2 inhibitors and uses thereof
申请人:Nimbus Lakshmi, Inc.
公开号:US10253046B2
公开(公告)日:2019-04-09
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
本发明提供了用于抑制 TYK2 和治疗 TYK2 介导的疾病的化合物、其组合物和使用方法。
WO2021062245A5
申请人:——
公开号:WO2021062245A5
公开(公告)日:2023-08-24
[EN] HYPOXIA ACTIVATED DRUGS OF NITROGEN MUSTARD ALKYLATORS<br/>[FR] MÉDICAMENTS ACTIVÉS PAR L'HYPOXIE À BASE D'AGENTS ALKYLANTS DE LA FAMILLE DES MOUTARDES AZOTÉES